Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Lantus (insulin glargine) and Semglee (insulin glargine-yfgn) are both long-acting insulins used to manage blood sugar levels in people with Type 1 and Type 2 diabetes. They are similar in that they contain the same active ingredient, are both injected under the skin once daily, and help control blood sugar levels throughout the day. However, there are some differences between the two medications. Semglee is an interchangeable biosimilar to Lantus, meaning it can be substituted for Lantus without needing approval from your prescriber. This makes Semglee a potentially lower-cost alternative. Both medications come in vials and prefilled pens. The side effects and risks, such as low blood sugar and weight gain, are similar for both medications.
Lantus (insulin glargine)
Semglee (insulin glargine)
Lantus (insulin glargine)
Semglee (insulin glargine)
Summary of Lantus vs. Semglee
Summary for Insulin
Prescription only
Lantus (insulin glargine) is a type of long-acting insulin. It's used to help manage blood sugar levels in people with Type 1 diabetes or Type 2 diabetes. Lantus (insulin glargine) is injected under the skin once daily. Your dose will depend on a few things, such as the type of diabetes you have and your blood sugar levels. This medication comes in a vial (Lantus) as well as in a prefilled insulin pen (Lantus Solostar). Some side effects include upper respiratory tract infections. It can also cause redness and swelling at the injection site.
Summary for Insulin
Prescription only
Semglee (insulin glargine-yfgn or insulin glargine) is a long-acting insulin. It's used to manage blood sugar levels in adults and children with Type 1 diabetes or Type 2 diabetes. Semglee (insulin glargine) is injected under the skin, typically once daily. Your care team will determine your dose of Semglee (insulin glargine) based on different factors, such as your diet and blood sugar levels. Semglee (insulin glargine) comes as a vial and a prefilled insulin pen. Some side effects of this medication include redness and swelling at the injection site, and upper respiratory tract infections.
<br>
Semglee (insulin glargine) is an interchangeable biosimilar alternative to Lantus (insulin glargine).